Chronic dopaminergic stimulation in Parkinson's disease: from dyskinesias to impulse control disorders
暂无分享,去创建一个
Erwan Bezard | Valerie Voon | Christelle Baunez | Jeff Wickens | J. Wickens | E. Bézard | J. Obeso | V. Voon | C. Baunez | Manuel Rodriguez | N. Pavón | P. Fernagut | J. Juncos | Pierre-Olivier Fernagut | José A Obeso | Manuel Rodriguez | Jorge L Juncos | Nancy Pavon | N. Pavón
[1] Paul Greengard,et al. Critical Involvement of cAMP/DARPP-32 and Extracellular Signal-Regulated Protein Kinase Signaling in l-DOPA-Induced Dyskinesia , 2007, The Journal of Neuroscience.
[2] W. Schultz,et al. Neuronal activity in monkey ventral striatum related to the expectation of reward , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[3] G E Stelmach,et al. Movement preparation in Parkinson's disease. The use of advance information. , 1986, Brain : a journal of neurology.
[4] K. Fuxe,et al. Increase in A2A receptors in the nucleus accumbens after extended cocaine self-administration and its disappearance after cocaine withdrawal , 2007, Brain Research.
[5] R. Boakes,et al. Motivational control after extended instrumental training , 1995 .
[6] Regina Katzenschlager,et al. Punding in Parkinson's disease: Its relation to the dopamine dysregulation syndrome , 2004, Movement disorders : official journal of the Movement Disorder Society.
[7] V. Voon,et al. Medication-related impulse control and repetitive behaviors in Parkinson disease. , 2007, Archives of neurology.
[8] A J Lees,et al. Relationship between impulsive sensation seeking traits, smoking, alcohol and caffeine intake, and Parkinson’s disease , 2005, Journal of Neurology, Neurosurgery & Psychiatry.
[9] A. Sorkin,et al. Rapid regulation of the dopamine transporter: role in stimulant addiction? , 2004, Neuropharmacology.
[10] Erwan Bezard,et al. Pathophysiology of levodopa-induced dyskinesia: Potential for new therapies , 2001, Nature Reviews Neuroscience.
[11] J. González-Mora,et al. Heterogeneous Dopamine Neurochemistry in the Striatum: The Fountain-Drain Matrix , 2006, Journal of Pharmacology and Experimental Therapeutics.
[12] G. Halliday,et al. The progression of pathology in longitudinally followed patients with Parkinson’s disease , 2008, Acta Neuropathologica.
[13] J. Marinus,et al. Psychotic and compulsive symptoms in Parkinson's disease , 2009, Movement disorders : official journal of the Movement Disorder Society.
[14] P. Sokoloff,et al. Induction of dopamine D3 receptor expression as a mechanism of behavioral sensitization to levodopa. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[15] E. Bézard,et al. Initial clinical manifestations of Parkinson's disease: features and pathophysiological mechanisms , 2009, The Lancet Neurology.
[16] B. Sahakian,et al. Predictors of punding in Parkinson's disease: Results from a questionnaire survey , 2007, Movement disorders : official journal of the Movement Disorder Society.
[17] P. Jenner,et al. Alterations in preproenkephalin and adenosine‐2a receptor mRNA, but not preprotachykinin mRNA correlate with occurrence of dyskinesia in normal monkeys chronically treated with l‐DOPA , 2000, The European journal of neuroscience.
[18] J. Régis,et al. Addiction in Parkinson's disease: Impact of subthalamic nucleus deep brain stimulation , 2005, Movement disorders : official journal of the Movement Disorder Society.
[19] P. Apicella,et al. Reward-related neuronal activity in the subthalamic nucleus of the monkey , 2005, Neuroreport.
[20] K. Berridge,et al. The neural basis of drug craving: An incentive-sensitization theory of addiction , 1993, Brain Research Reviews.
[21] J. Girault,et al. Persistent Increase in Olfactory Type G-Protein α Subunit Levels May Underlie D1 Receptor Functional Hypersensitivity in Parkinson Disease , 2004, The Journal of Neuroscience.
[22] N. A. Buchwald,et al. Effects of caudate nuclei or frontal cortical ablations in kittens: Motor activity and visual discrimination performance in neonatal and juvenile kittens , 1978, Experimental Neurology.
[23] R. Kessler,et al. The Prevalence and Correlates of Eating Disorders in the National Comorbidity Survey Replication , 2007, Biological Psychiatry.
[24] G. Di Chiara,et al. Agonist-induced homologous and heterologous sensitization to D-1- and D-2-dependent contraversive turning. , 1987, European journal of pharmacology.
[25] Nikolaus R. McFarland,et al. Striatonigrostriatal Pathways in Primates Form an Ascending Spiral from the Shell to the Dorsolateral Striatum , 2000, The Journal of Neuroscience.
[26] E. Vaadia,et al. Coincident but Distinct Messages of Midbrain Dopamine and Striatal Tonically Active Neurons , 2004, Neuron.
[27] Y. Shaham,et al. Role of ERK in cocaine addiction , 2006, Trends in Neurosciences.
[28] O. Rascol,et al. Development of dyskinesias in a 5‐year trial of ropinirole and L‐dopa , 2006, Movement disorders : official journal of the Movement Disorder Society.
[29] C. Marsden,et al. Disturbance of sequential movements in patients with Parkinson's disease. , 1987, Brain : a journal of neurology.
[30] Paul Greengard,et al. Cell type–specific regulation of DARPP-32 phosphorylation by psychostimulant and antipsychotic drugs , 2008, Nature Neuroscience.
[31] J. Vander Bilt,et al. Estimating the prevalence of disordered gambling behavior in the United States and Canada: a research synthesis. , 1999, American journal of public health.
[32] Y. Agid,et al. Pathological gambling in Parkinson's disease improves on chronic subthalamic nucleus stimulation , 2006, Movement disorders : official journal of the Movement Disorder Society.
[33] E. Bézard,et al. Pharmacological Analysis Demonstrates Dramatic Alteration of D1 Dopamine Receptor Neuronal Distribution in the Rat Analog of l-DOPA-Induced Dyskinesia , 2009, The Journal of Neuroscience.
[34] B Bioulac,et al. Dopamine agonist-induced dyskinesias are correlated to both firing pattern and frequency alterations of pallidal neurones in the MPTP-treated monkey. , 2001, Brain : a journal of neurology.
[35] A. Doupe,et al. Interruption of a basal ganglia–forebrain circuit prevents plasticity of learned vocalizations , 2000, Nature.
[36] S. Cragg,et al. Dopamine spillover after quantal release: Rethinking dopamine transmission in the nigrostriatal pathway , 2008, Brain Research Reviews.
[37] A. Faure,et al. Lesion to the Nigrostriatal Dopamine System Disrupts Stimulus-Response Habit Formation , 2005, The Journal of Neuroscience.
[38] A. Lang,et al. Prospective prevalence of pathologic gambling and medication association in Parkinson disease , 2006, Neurology.
[39] Thomas Boraud,et al. Attenuation of levodopa-induced dyskinesia by normalizing dopamine D3 receptor function , 2003, Nature Medicine.
[40] Qin Li,et al. The 3-Hydroxy-3-Methylglutaryl-CoA Reductase Inhibitor Lovastatin Reduces Severity of l-DOPA-Induced Abnormal Involuntary Movements in Experimental Parkinson's Disease , 2008, The Journal of Neuroscience.
[41] E. Bézard,et al. Molecular mechanisms of l-DOPA-induced dyskinesia. , 2011, International review of neurobiology.
[42] P. Emson,et al. Altered vesicular dopamine storage in Parkinson's disease: a premature demise , 2008, Trends in Neurosciences.
[43] O. Hornykiewicz,et al. Levodopa-induced motor complications are associated with alterations of glutamate receptors in Parkinson's disease , 2003, Neurobiology of Disease.
[44] B. Everitt,et al. Cocaine Seeking Habits Depend upon Dopamine-Dependent Serial Connectivity Linking the Ventral with the Dorsal Striatum , 2008, Neuron.
[45] J A Obeso,et al. Slow oscillatory activity and levodopa-induced dyskinesias in Parkinson's disease. , 2006, Brain : a journal of neurology.
[46] S. Wong,et al. Internet gambling and other pathological gambling in Parkinson's disease: A case series , 2007, Movement disorders : official journal of the Movement Disorder Society.
[47] S Fahn,et al. The spectrum of levodopa-induced dyskinesias. , 2000, Annals of neurology.
[48] J. Dostrovsky,et al. Neuronal recordings in Parkinson's disease patients with dyskinesias induced by apomorphine. , 2000, Annals of neurology.
[49] T. Robbins,et al. Review Personality, Addiction, Dopamine: Insights from Parkinson's Disease Table 1. Possible Site of Striatal Dopamine Dysfunction Causing Different Motor and Cognitive Symptoms in Parkinson's Disease , 2022 .
[50] Luigi F. Agnati,et al. The emergence of the volume transmission concept 1 Published on the World Wide Web on 12 January 1998. 1 , 1998, Brain Research Reviews.
[51] K. Campbell,et al. A neural correlate of response bias in monkey caudate nucleus , 2022 .
[52] C. Konradi,et al. Spatiotemporal Pattern of Striatal ERK1/2 Phosphorylation in a Rat Model of L-DOPA–Induced Dyskinesia and the Role of Dopamine D1 Receptors , 2007, Biological Psychiatry.
[53] R. J. McDonald,et al. A triple dissociation of memory systems: hippocampus, amygdala, and dorsal striatum. , 1993, Behavioral neuroscience.
[54] M. Potenza. Non-substance and substance addictions. , 2009, Addiction.
[55] J. Wickens,et al. A cellular mechanism of reward-related learning , 2001, Nature.
[56] J M Smith,et al. Compulsive buying: a report of 20 cases. , 1994, The Journal of clinical psychiatry.
[57] B. Balleine,et al. Inactivation of dorsolateral striatum enhances sensitivity to changes in the action–outcome contingency in instrumental conditioning , 2006, Behavioural Brain Research.
[58] M. West,et al. Changes in activity of the striatum during formation of a motor habit , 2007, The European journal of neuroscience.
[59] M. Kimura. Behaviorally contingent property of movement-related activity of the primate putamen. , 1990, Journal of neurophysiology.
[60] P. Kuhl,et al. Birdsong and human speech: common themes and mechanisms. , 1999, Annual review of neuroscience.
[61] W. Ondo,et al. Predictors of impulsivity and reward seeking behavior with dopamine agonists. , 2008, Parkinsonism & related disorders.
[62] B. Everitt,et al. Emotion and motivation: the role of the amygdala, ventral striatum, and prefrontal cortex , 2002, Neuroscience & Biobehavioral Reviews.
[63] T. Robbins,et al. Probabilistic learning and reversal deficits in patients with Parkinson’s disease or frontal or temporal lobe lesions: possible adverse effects of dopaminergic medication , 2000, Neuropsychologia.
[64] F. Jiménez-Jiménez,et al. Pathologic gambling in Parkinson's disease: A behavioral manifestation of pharmacologic treatment? , 2000, Movement disorders : official journal of the Movement Disorder Society.
[65] J. Hollerman,et al. Influence of reward expectation on behavior-related neuronal activity in primate striatum. , 1998, Journal of neurophysiology.
[66] P. Jenner,et al. Plasma levels of rotigotine and the reversal of motor deficits in MPTP-treated primates , 2007, Behavioural pharmacology.
[67] A. Graybiel,et al. The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson's disease. , 1999, Brain : a journal of neurology.
[68] Gilberto Fisone,et al. Increased D1 dopamine receptor signaling in levodopa‐induced dyskinesia , 2005, Annals of neurology.
[69] J. Kassubek,et al. Dopamine Agonists and their risk to induce psychotic episodes in Parkinson's disease: a case-control study , 2009, BMC neurology.
[70] Erwan Bezard,et al. Involvement of Sensorimotor, Limbic, and Associative Basal Ganglia Domains in L-3,4-Dihydroxyphenylalanine-Induced Dyskinesia , 2005, The Journal of Neuroscience.
[71] A. Graybiel,et al. The substantia nigra of the human brain. I. Nigrosomes and the nigral matrix, a compartmental organization based on calbindin D(28K) immunohistochemistry. , 1999, Brain : a journal of neurology.
[72] R. Katzenschlager,et al. Punding and dyskinesias , 2006, Movement disorders : official journal of the Movement Disorder Society.
[73] A. Lang,et al. Punding prevalence in Parkinson's disease , 2007, Movement Disorders.
[74] G. Rylander. Psychoses and the punding and choreiform syndromes in addiction to central stimulant drugs. , 1972, Psychiatria, neurologia, neurochirurgia.
[75] J. Obeso,et al. Clinical Features, Pathophysiology, and Treatment of Levodopa-Induced Dyskinesias in Parkinson's Disease , 2012, Parkinson's disease.
[76] Paul Greengard,et al. Loss of bidirectional striatal synaptic plasticity in L-DOPA–induced dyskinesia , 2003, Nature Neuroscience.
[77] H. E. Rosvold,et al. Behavioral effects of selective ablation of the caudate nucleus. , 1967, Journal of comparative and physiological psychology.
[78] N. Pavón,et al. ERK Phosphorylation and FosB Expression Are Associated with L-DOPA-Induced Dyskinesia in Hemiparkinsonian Mice , 2006, Biological Psychiatry.
[79] Yen F. Tai,et al. Compulsive drug use linked to sensitized ventral striatal dopamine transmission , 2006, Annals of neurology.
[80] J. Doyon. Motor sequence learning and movement disorders , 2008, Current opinion in neurology.
[81] R. J. McDonald,et al. Multiple Parallel Memory Systems in the Brain of the Rat , 2002, Neurobiology of Learning and Memory.
[82] J A Obeso,et al. Pathophysiology of levodopa-induced dyskinesias in Parkinson's disease: problems with the current model. , 2000, Annals of neurology.
[83] D. Grosset,et al. Problematic gambling on dopamine agonists: Not such a rarity , 2006, Movement disorders : official journal of the Movement Disorder Society.
[84] Ronald J. Faber,et al. Estimated prevalence of compulsive buying behavior in the United States. , 2006, The American journal of psychiatry.
[85] C. Colosimo,et al. Prevalence and clinical features of hedonistic homeostatic dysregulation in Parkinson's disease , 2005, Movement disorders : official journal of the Movement Disorder Society.
[86] S. Young,et al. 5-hydroxydopamine-labeled dopaminergic axns: Three-dimensional reconstructions of axons, synapses and postsynaptic targets in rat neostriatum , 1994, Neuroscience.
[87] B. Balleine,et al. Lesions of dorsolateral striatum preserve outcome expectancy but disrupt habit formation in instrumental learning , 2004, The European journal of neuroscience.
[88] K. Fuxe,et al. Localization of monoamines in the lower brain stem , 1964, Experientia.
[89] V. Voon,et al. Medication-related impulse control and repetitive behaviors in Parkinson's disease , 2007, Current opinion in neurology.
[90] Vesna Sossi,et al. Levodopa-induced changes in synaptic dopamine levels increase with progression of Parkinson's disease: implications for dyskinesias. , 2004, Brain : a journal of neurology.
[91] G. Brighetti,et al. Prevalence of pathological gambling in patients with Parkinson's disease , 2006, Movement disorders : official journal of the Movement Disorder Society.
[92] G. Fénelon. Psychosis in Parkinson's Disease: Phenomenology, Frequency, Risk Factors, and Current Understanding of Pathophysiologic Mechanisms , 2008, CNS Spectrums.
[93] A. Lawrence,et al. Factors influencing susceptibility to compulsive dopaminergic drug use in Parkinson disease , 2005, Neurology.
[94] A. Graybiel,et al. Subdivisions of the dopamine-containing A8-A9-A10 complex identified by their differential mesostriatal innervation of striosomes and extrastriosomal matrix , 1987, Neuroscience.
[95] J. Obeso,et al. Levodopa‐induced dyskinesias in Parkinson's disease: Clinical and pharmacological classification , 1992, Movement disorders : official journal of the Movement Disorder Society.
[96] Christopher D. Adams,et al. The Effect of the Instrumental Training Contingency on Susceptibility to Reinforcer Devaluation , 1983 .
[97] P. Moberg,et al. Association of dopamine agonist use with impulse control disorders in Parkinson disease. , 2006, Archives of neurology.
[98] E. Bézard,et al. Increased slow oscillatory activity in substantia nigra pars reticulata triggers abnormal involuntary movements in the 6-OHDA-lesioned rat in the presence of excessive extracelullar striatal dopamine , 2006, Neurobiology of Disease.
[99] C. Goetz,et al. Levodopa‐induced dyskinesias , 2007, Movement disorders : official journal of the Movement Disorder Society.
[100] Michael J. Frank,et al. Hold Your Horses: Impulsivity, Deep Brain Stimulation, and Medication in Parkinsonism , 2007, Science.
[101] J. Wickens,et al. Dopamine reverses the depression of rat corticostriatal synapses which normally follows high-frequency stimulation of cortex In vitro , 1996, Neuroscience.
[102] J. Villablanca,et al. Effects of caudate nuclei or frontal cortex ablations in cats. IV. Bar pressing, maze learning, and performance , 1976, Experimental Neurology.
[103] M. Kuhar,et al. The dopamine transporter is localized to dendritic and axonal plasma membranes of nigrostriatal dopaminergic neurons , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[104] R. Beninger,et al. Impaired Incentive Learning in Treated Parkinson’s Disease , 1996, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.
[105] R. Brambilla. Targeting Ras/ERK signaling in the striatum: will it help? , 2003, Molecular Psychiatry.
[106] T. Robbins,et al. The cognitive ability of an incident cohort of Parkinson's patients in the UK. The CamPaIGN study. , 2004, Brain : a journal of neurology.
[107] B. Knowlton,et al. Learning and memory functions of the Basal Ganglia. , 2002, Annual review of neuroscience.
[108] M. Amalric,et al. The subthalamic nucleus exerts opposite control on cocaine and 'natural' rewards , 2005, Nature Neuroscience.
[109] R. Cantello. Hedonistic homeostatic dysregulation in patients with Parkinson's disease on dopamine replacement therapies , 2000, Journal of neurology, neurosurgery, and psychiatry.
[110] A. Kelley. Ventral striatal control of appetitive motivation: role in ingestive behavior and reward-related learning , 2004, Neuroscience & Biobehavioral Reviews.
[111] A. Lang,et al. Prevalence of repetitive and reward-seeking behaviors in Parkinson disease , 2006, Neurology.
[112] L. Metman,et al. Amantadine as treatment for dyskinesias and motor fluctuations in Parkinson's disease , 1998, Neurology.